CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
PHAGOBURN aims to tackle multidrug-resistant infections in burn patients using phage therapy. The project will evaluate the safety and effectiveness of phage cocktails against specific bacteria, addressing a critical gap in treatment options for severe infections.
Sepsis is the major problem of large burn patients and a predominant cause of death.
The burn wound pathology, combined to a global intensive use of antibiotics (ATB), put patients at high risk of suffering from multidrug resistant (MDR) infections, notably carried out by the Gram-negative bacteria species:
Pseudomonas aeruginosa or Escherichia coli.
But the last Gram- ATB is more than 20 years old and impeded by spread out exponential resistance.
New ATB with genuine mode of action to target cu…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
France, NANTES
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
France, Boufféré
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
ECOLE ROYALE MILITAIRE - KONINKLIJKE MILITAIRE SCHOOL
Belgium, Bruxelles / Brussel
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Switzerland, Lausanne
Type: Public body
Activity type: Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
